This company discontinued its dividend after 2021.
Based on TTM and annual data · Not a buy/sell signal
This company does not pay dividends
Last dividend was paid in 2021. The company has not paid dividends in the last 4 years.
Does Cegedim (ALCGM.XPAR) pay a dividend?
Cegedim (ALCGM.XPAR) stopped paying a dividend after 2021 and pays nothing today. The business does generate free cash flow of €78 million, so the absence of a dividend is a capital-allocation choice rather than an inability to pay. All figures are computed from company filings; this is analysis, not investment advice.
Frequently asked
Does Cegedim (ALCGM.XPAR) pay a dividend?+
No. Cegedim (ALCGM.XPAR) does not currently pay a dividend. The last payment in our data was in 2021, and nothing has been paid since.
How does Cegedim return cash to shareholders?+
It largely does not. Cegedim pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.
Could Cegedim afford to pay a dividend?+
On the numbers, yes. Cegedim generated €78 million of free cash flow, which is about €5.69 per share. If it paid out half of that, the dividend would be roughly €2.84 per share, a yield of about 29.0% at the current price. That is an illustration of capacity, not a prediction: the company has given no indication it intends to pay one.
Which healthcare companies do pay dividends?+
Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Cegedim.
Peers
Health Information Services · Pick stocks to compare with ALCGM.XPAR
Held by ETFs
ALCGM.XPAR is in 1 US ETF. The largest of them, with ALCGM.XPAR's weight in each:
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ALCGM.XPAR
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.